Fosun Pharma announces resignation of senior vice president

Shanghai Fosun Pharmaceutical Group (SSE:600196) announced the resignation of Senior Vice President Li Dongjiu, effective April 23, 2025. According to the company's announcement, Mr. Li's resignation is due to retirement. Fosun Pharma's board of directors expressed its gratitude to Mr. Li for his contributions during his tenure as a senior executive. The company affirmed that the board of directors ensures that there are no false records, misleading statements, or major omissions in the announcement.